These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 7492093

  • 1. Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci.
    Pankuch GA, Visalli MA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1499-504. PubMed ID: 7492093
    [Abstract] [Full Text] [Related]

  • 2. Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone.
    Pankuch GA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2905-7. PubMed ID: 7695281
    [Abstract] [Full Text] [Related]

  • 3. In vitro susceptibility of 90 penicillin-susceptible and -resistant pneumococci to penicillin G, amoxicillin, amoxicillin/clavulanate, cefaclor, cefuroxime, cefpodoxime, cefixime and imipenem.
    Hupková H, Trupl J.
    Folia Microbiol (Praha); 1998 Dec; 43(1):68-70. PubMed ID: 9569631
    [Abstract] [Full Text] [Related]

  • 4. In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Verhaegen J, Verbist L.
    J Antimicrob Chemother; 1998 Mar; 41(3):381-5. PubMed ID: 9578165
    [Abstract] [Full Text] [Related]

  • 5. In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir.
    Spangler SK, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2902-4. PubMed ID: 7695280
    [Abstract] [Full Text] [Related]

  • 6. Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams.
    Spangler SK, Jacobs MR, Appelbaum PC.
    J Antimicrob Chemother; 1997 Feb; 39(2):141-8. PubMed ID: 9069533
    [Abstract] [Full Text] [Related]

  • 7. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics.
    Liñares J, Alonso T, Pérez JL, Ayats J, Domínguez MA, Pallarés R, Martín R.
    J Antimicrob Chemother; 1992 Sep; 30(3):279-88. PubMed ID: 1452492
    [Abstract] [Full Text] [Related]

  • 8. Activities and time-kill studies of selected penicillins, beta-lactamase inhibitor combinations, and glycopeptides against Enterococcus faecalis.
    Hoellman DB, Visalli MA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1998 Apr; 42(4):857-61. PubMed ID: 9559796
    [Abstract] [Full Text] [Related]

  • 9. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
    Peric M, Browne FA, Jacobs MR, Appelbaum PC.
    Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
    [Abstract] [Full Text] [Related]

  • 10. Comparative activity of twelve beta-lactam drugs tested against penicillin-resistant Streptococcus pneumoniae from five medical centers: effects of serum protein and capsular material on potency and spectrum as measured by reference tests.
    Johnson DM, Doern GV, Haugen TA, Hindler J, Washington JA, Jones RN.
    Diagn Microbiol Infect Dis; 1996 Jul; 25(3):137-41. PubMed ID: 8902410
    [Abstract] [Full Text] [Related]

  • 11. In vitro susceptibilities of 176 clinical isolates of Streptococcus pneumoniae to 11 beta-lactams, erythromycin, and tetracycline.
    Vanhoof R, Carpentier M, Glupczynski Y, Gordts B, Magerman K, Nyssen HJ, Simon A, Surmont I, Van de Vyvere M, Van Landuyt H, Van Nimmen L, Van Noyen R.
    Acta Clin Belg; 1996 Jul; 51(6):377-85. PubMed ID: 8997755
    [Abstract] [Full Text] [Related]

  • 12. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae.
    Fenoll A, Giménez MJ, Robledo O, Aguilar L, Tarragó D, Granizo JJ, Martín-Herrero JE.
    Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):75-80. PubMed ID: 17943330
    [Abstract] [Full Text] [Related]

  • 13. Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology.
    Visalli MA, Jacobs MR, Appelbaum PC.
    J Antimicrob Chemother; 1996 Jan; 37(1):77-84. PubMed ID: 8647777
    [Abstract] [Full Text] [Related]

  • 14. E test for studying in vitro activity of seven antimicrobial agents against penicillin-susceptible and penicillin-resistant pneumococci.
    Li J, Zhang Y, Chen Y, Hao F, Chen Y.
    Chin Med J (Engl); 2000 Jul; 113(7):628-31. PubMed ID: 11776034
    [Abstract] [Full Text] [Related]

  • 15. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis.
    Tweardy DJ, Jacobs MR, Speck WT.
    J Antimicrob Chemother; 1983 Aug; 12(2):133-9. PubMed ID: 6555189
    [Abstract] [Full Text] [Related]

  • 16. In vitro selection of one-step mutants of Streptococcus pneumoniae resistant to different oral beta-lactam antibiotics is associated with alterations of PBP2x.
    Sifaoui F, Kitzis MD, Gutmann L.
    Antimicrob Agents Chemother; 1996 Jan; 40(1):152-6. PubMed ID: 8787897
    [Abstract] [Full Text] [Related]

  • 17. In vitro activities of oral beta-lactams at concentrations achieved in humans against penicillin-susceptible and -resistant pneumococci and potential to select resistance.
    Thorburn CE, Knott SJ, Edwards DI.
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1973-9. PubMed ID: 9687392
    [Abstract] [Full Text] [Related]

  • 18. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
    Pankuch GA, Jacobs MR, Appelbaum PC.
    J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200
    [Abstract] [Full Text] [Related]

  • 19. MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agents.
    Spangler SK, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1997 Jan; 41(1):148-55. PubMed ID: 8980771
    [Abstract] [Full Text] [Related]

  • 20. Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci.
    Ednie LM, Visalli MA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1950-2. PubMed ID: 8843313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.